Fall Pharmacy Conference

Advancing Pharmacy Science, Education and Practice in the Commonwealth

Accredited through the Kentucky State Board of Pharmacy for application to Kentucky licensure only - Certified for 0.5 CEU's (5 contact hours).

Friday, October, 19th
7:30 a.m. - 3:00 p.m.

Keeneland Health Education Center
JP Morgan Chase Room
Saint Joseph Office Park
Bldg D, Fourth Floor
Lexington, Kentucky 40504

859.313.2187

This statewide health care symposium is focused on pharmacy education. Speakers will discuss the latest updates and advancements in pharmacology, including a review of new drugs and new treatment strategies. Speakers also will critique recently published clinical trials and research findings.

A "Question & Answer" session will be held after each lecture. Saint Joseph Clinical Pharmacy Services is dedicated to excellence and innovation in the continuum of pharmaceutical care and education. This program will allow participants to become part of this continuum as they further their education.

Conference Agenda

7:30-8:15 am  Complimentary Breakfast

8:15-8:30 am  Welcome and Introductions

8:30-9:30 am    New Drug Update 2012
Brian Lindvahl, PharmD, BCPS
Clinical Pharmacy Services
Saint Joseph Hospital
0.1 CEU  KY BOP #

9:30-10:30 am              Recent Advances in the Treatment of Breast Cancer
Patrick Ratliff, PharmD
Clinical Pharmacy Services
Saint Joseph Hospital
0.1 CEU  KY BOP #

10:30-11:00 am  Break

11:00-12:00 pm  From the FDA to the Bedside: Setting and Revising Antibacterial Susceptibility Breakpoints
W. Russ Judd, PharmD, BCPS
Clinical Pharmacy Services
Saint Joseph Hospital
0.1 CEU  KY BOP #

12:00-1:00 pm  Lunch

1:00-2:00 pm  Updates in Antithrombotic Therapy
Shawn King, PharmD
Clinical Pharmacy Services
Saint Joseph East
0.1 CEU  KY BOP #

2:00-3:00 pm  Review of Therapy Options and the Role of Pharmacists in Treating Chemotherapy Related Toxicities
Kim Flynn, PharmD
Clinical Pharmacy Services
Saint Joseph Hospital
0.1 CEU  KY BOP #    

Each presentation will last approx 50 minutes with 5 minutes for Q/A and 5 minutes change over

Program Coordinators: Kip Eberwein, RPh & Lauren Cottingham, PharmD

Objectives

8:30-9:30

1. Describe the labeled and off label indications and common dosing for these medications
 2. Identify each items risks and benefits over presently available drugs 
 3. Recognize the potential for adverse effects of each medication and the precautions needed to minimize their occurrence 
 4. Identify relative and absolute contraindications to these medications

9:30-10:30 

1. Describe the pathophysiology and epidemiology of breast cancer
2. Discuss several cellular targets for breast cancer medications
3. Identify new medications available for the treatment of breast cancer
4. Review noteworthy recent breast cancer therapy-related literature

11:00-12:00

1. Examine major criteria for setting and revising antibacterial susceptibility breakpoints
2. Analyze current trends in antimicrobial resistance
3. Design antibacterial regimens that maximize pharmacodynamic outcomes based on MIC data

1:00-2:00 

1. Describe the pharmacology and MOA for new antithrombotic agents
2. Evaluate the ADR’s & side effects associated with these agents
3. Determine appropriate doses depending on pt’s renal & hepatic function

2:00-3:00 

1. Recall the newest antidotes for methotrexate and 5-fluorouracil induced toxicities
2. Describe strategies for determining if an experimental antidote is available
3. Review FDA approved antidotes for chemotherapy induced toxicities